269 related articles for article (PubMed ID: 31494310)
1. Hormonal therapies in uterine sarcomas, aggressive angiomyxoma, and desmoid-type fibromatosis.
Pannier D; Cordoba A; Ryckewaert T; Robin YM; Penel N
Crit Rev Oncol Hematol; 2019 Nov; 143():62-66. PubMed ID: 31494310
[TBL] [Abstract][Full Text] [Related]
2. Hormonal therapy in uterine sarcomas.
Zang Y; Dong M; Zhang K; Gao C; Guo F; Wang Y; Xue F
Cancer Med; 2019 Apr; 8(4):1339-1349. PubMed ID: 30897294
[TBL] [Abstract][Full Text] [Related]
3. Hormonal therapy of endometrial stromal sarcoma.
Reich O; Regauer S
Curr Opin Oncol; 2007 Jul; 19(4):347-52. PubMed ID: 17545798
[TBL] [Abstract][Full Text] [Related]
4. Clinical management of uterine sarcomas.
Amant F; Coosemans A; Debiec-Rychter M; Timmerman D; Vergote I
Lancet Oncol; 2009 Dec; 10(12):1188-98. PubMed ID: 19959075
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the treatment of sarcomas in gynecology.
Lange SS; Novetsky AP; Powell MA
Discov Med; 2014 Sep; 18(98):133-40. PubMed ID: 25227754
[TBL] [Abstract][Full Text] [Related]
6. Current concepts in the imaging of uterine sarcoma.
Tirumani SH; Ojili V; Shanbhogue AK; Fasih N; Ryan JG; Reinhold C
Abdom Imaging; 2013 Apr; 38(2):397-411. PubMed ID: 22699695
[TBL] [Abstract][Full Text] [Related]
7. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.
Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Belda MALF; Averous G; Leroux A; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
Gynecol Oncol; 2022 Nov; 167(2):373-389. PubMed ID: 36114030
[TBL] [Abstract][Full Text] [Related]
8. Systemic treatment in adult uterine sarcomas.
Desar IME; Ottevanger PB; Benson C; van der Graaf WTA
Crit Rev Oncol Hematol; 2018 Feb; 122():10-20. PubMed ID: 29458779
[TBL] [Abstract][Full Text] [Related]
9. Uterine sarcoma and aromatase inhibitors: Tom Baker Cancer Centre experience and review of the literature.
Altman AD; Nelson GS; Chu P; Nation J; Ghatage P
Int J Gynecol Cancer; 2012 Jul; 22(6):1006-12. PubMed ID: 22740004
[TBL] [Abstract][Full Text] [Related]
10. Aromatase expression in low-grade endometrial stromal sarcomas: an immunohistochemical study.
Reich O; Regauer S
Mod Pathol; 2004 Jan; 17(1):104-8. PubMed ID: 14631363
[TBL] [Abstract][Full Text] [Related]
11. Staging of uterine sarcomas.
Tse KY; Crawford R; Ngan HY
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):733-49. PubMed ID: 21752716
[TBL] [Abstract][Full Text] [Related]
12. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.
Burghaus S; Halmen S; Gass P; Mehlhorn G; Schrauder MG; Lux MP; Renner SP; Beckmann MW; Hein A; Thiel FC
Arch Gynecol Obstet; 2016 Aug; 294(2):343-51. PubMed ID: 26711836
[TBL] [Abstract][Full Text] [Related]
13. Hormone receptor expression in uterine sarcomas: prognostic and therapeutic roles.
Ioffe YJ; Li AJ; Walsh CS; Karlan BY; Leuchter R; Forscher C; Cass I
Gynecol Oncol; 2009 Dec; 115(3):466-71. PubMed ID: 19767065
[TBL] [Abstract][Full Text] [Related]
14. [Endometrial stromal sarcoma: complete response to therapy with aromatase-inhibitor, anastrozole].
Lisianskaia AS; Manikhas GM; Fadeeva EP; Fedosenko KV; Tapil'skaia NI
Vopr Onkol; 2010; 56(1):91-3. PubMed ID: 20361625
[No Abstract] [Full Text] [Related]
15. [Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours].
Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Le Frere Belda MA; Averous G; Leroux A; Bataillon G; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
Bull Cancer; 2024 Jan; 111(1):97-116. PubMed ID: 37806863
[TBL] [Abstract][Full Text] [Related]
16. The treatment of uterine sarcomas.
Reichardt P
Ann Oncol; 2012 Sep; 23 Suppl 10():x151-7. PubMed ID: 22987952
[TBL] [Abstract][Full Text] [Related]
17. Uterine sarcomas.
Mbatani N; Olawaiye AB; Prat J
Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():51-58. PubMed ID: 30306577
[TBL] [Abstract][Full Text] [Related]
18. Hormonal therapies and gynaecological cancers.
Garrett A; Quinn MA
Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):407-21. PubMed ID: 17884734
[TBL] [Abstract][Full Text] [Related]
19. Aromatase inhibitor therapy for endometrial stromal sarcoma - two-centre experience.
Serkies K; Abacjew-Chmyłko A; Wieczorek-Rutkowska M; Pęksa R
Ginekol Pol; 2018; 89(11):607-610. PubMed ID: 30508212
[TBL] [Abstract][Full Text] [Related]
20. Low-grade endometrial stromal sarcoma of the ectocervix after therapy for breast cancer.
Boardman CH; Webb MJ; Jefferies JA
Gynecol Oncol; 2000 Oct; 79(1):120-3. PubMed ID: 11006043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
